Literature DB >> 8263062

[11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.

R A Koeppe1, K A Frey, G K Mulholland, M R Kilbourn, A Buck, K S Lee, D E Kuhl.   

Abstract

Quantitative estimation of cerebral muscarinic receptors was investigated with the use of the antagonist [11C]tropanyl benzilate ([11C]TRB) and positron emission tomography (PET). Kinetic modeling alternatives were examined with the goal of identifying an analysis method providing stable receptor measures, yet avoiding biases from inappropriate reductions in model complexity. Dynamic PET scans were performed on six young normal volunteers. Several modeling approaches yielding relative receptor density measures were evaluated: (a) a single "late" scan using relative tracer concentration values; (b) a slope estimate from graphic analysis (Patlak plot); (c) a two-compartment, two-parameter model (transport and total ligand distribution volume); (d) a three-compartment, two-parameter model using the free+nonspecific distribution volume, DV', fixed to the cerebellar value; (e) an early scan for transport, a fixed value for DV', and a single late scan for the binding rate constant; and (f) a three-compartment, three-parameter model. Both computer simulations and PET scan results indicate all methods provide receptor density index measures with the same rank order as in vitro measures. Oversimplified approaches (methods 1 and 2) yield a more highly nonlinear relation between the estimated receptor density index and the known receptor density than do methods retaining greater model complexity (methods 3-6). However, noise propagation into the receptor measure is greater for the more complex methods. Reliable receptor density information can be obtained from kinetic [11C]TRB PET studies, with methods 3-5 providing the most appropriate levels of model complexity for estimates of relative muscarinic receptor density.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8263062     DOI: 10.1038/jcbfm.1994.13

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET.

Authors:  Taofeek K Owonikoko; Maria E Fabucci; Philip R Brown; Nighat Nisar; John Hilton; William B Mathews; Hayden T Ravert; Paige Rauseo; Kathryn Sandberg; Robert F Dannals; Zsolt Szabo
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

2.  PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against.

Authors:  Alberto Pupi; Flavio Mariano Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

3.  Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?

Authors:  L Ravasi; D O Kiesewetter; K Shimoji; G Lucignani; W C Eckelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12-07       Impact factor: 9.236

4.  Tracer kinetic modelling of receptor data with mathematical metabolite correction.

Authors:  C Burger; A Buck
Journal:  Eur J Nucl Med       Date:  1996-05

5.  In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate.

Authors:  D W Wooten; J D Moraino; A T Hillmer; J W Engle; O J Dejesus; D Murali; T E Barnhart; R J Nickles; R J Davidson; M L Schneider; J Mukherjee; B T Christian
Journal:  Synapse       Date:  2010-12-08       Impact factor: 2.562

6.  Estimation of brain 5HT2 receptor binding potential with a single-dose PET paradigm.

Authors:  M C Petit Taboué; J C Baron
Journal:  Eur J Nucl Med       Date:  1995-06

7.  Effect of intravascular ligand binding on parameter estimates derived from tracer kinetic modelling.

Authors:  A Buck; C Burger
Journal:  Eur J Nucl Med       Date:  1996-04

8.  Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.

Authors:  Hideo Tsukada; Hiroyuki Ohba; Masakatsu Kanazawa; Takeharu Kakiuchi; Norihiro Harada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-21       Impact factor: 9.236

9.  Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

Authors:  Zsolt Szabo; Una D McCann; Alan A Wilson; Ursula Scheffel; Taofeek Owonikoko; William B Mathews; Hayden T Ravert; John Hilton; Robert F Dannals; George A Ricaurte
Journal:  J Nucl Med       Date:  2002-05       Impact factor: 10.057

10.  Multiple linear analysis methods for the quantification of irreversibly binding radiotracers.

Authors:  Su Jin Kim; Jae Sung Lee; Yu Kyeong Kim; James Frost; Gary Wand; Mary E McCaul; Dong Soo Lee
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-16       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.